Ho, S.-Y.; Liu, P.-H.; Hsu, C.-Y.; Huang, Y.-H.; Liao, J.-I.; Su, C.-W.; Hou, M.-C.; Huo, T.-I.
Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Cancers 2023, 15, 1925.
https://doi.org/10.3390/cancers15071925
AMA Style
Ho S-Y, Liu P-H, Hsu C-Y, Huang Y-H, Liao J-I, Su C-W, Hou M-C, Huo T-I.
Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Cancers. 2023; 15(7):1925.
https://doi.org/10.3390/cancers15071925
Chicago/Turabian Style
Ho, Shu-Yein, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, and Teh-Ia Huo.
2023. "Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization" Cancers 15, no. 7: 1925.
https://doi.org/10.3390/cancers15071925
APA Style
Ho, S.-Y., Liu, P.-H., Hsu, C.-Y., Huang, Y.-H., Liao, J.-I., Su, C.-W., Hou, M.-C., & Huo, T.-I.
(2023). Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Cancers, 15(7), 1925.
https://doi.org/10.3390/cancers15071925
